Jitae A Kim1, Mihail G Chelu2, Na Li3,4,5. 1. Department of Medicine. 2. Division of Cardiology. 3. Department of Medicine (Section of Cardiovascular Research). 4. Department of Molecular Physiology and Biophysics. 5. Cardiovascular Research Institute, Baylor College of Medicine, Houston, Texas, USA.
Abstract
PURPOSE OF REVIEW: Atrial fibrillation is the most common sustained cardiac arrhythmia. In addition to traditional risk factors, it is increasingly recognized that a genetic component underlies atrial fibrillation development. This review aims to provide an overview of the genetic cause of atrial fibrillation and clinical applications, with a focus on recent developments. RECENT FINDINGS: Genome-wide association studies have now identified around 140 genetic loci associated with atrial fibrillation. Studies into the effects of several loci and their tentative gene targets have identified novel pathways associated with atrial fibrillation development. However, further validations of causality are still needed for many implicated genes. Genetic variants at identified loci also help predict individual atrial fibrillation risk and response to different therapies. SUMMARY: Continued advances in the field of genetics and molecular biology have led to significant insight into the genetic underpinnings of atrial fibrillation. Potential clinical applications of these studies include the identification of new therapeutic targets and development of genetic risk scores to optimize management of this common cardiac arrhythmia.
PURPOSE OF REVIEW: Atrial fibrillation is the most common sustained cardiac arrhythmia. In addition to traditional risk factors, it is increasingly recognized that a genetic component underlies atrial fibrillation development. This review aims to provide an overview of the genetic cause of atrial fibrillation and clinical applications, with a focus on recent developments. RECENT FINDINGS: Genome-wide association studies have now identified around 140 genetic loci associated with atrial fibrillation. Studies into the effects of several loci and their tentative gene targets have identified novel pathways associated with atrial fibrillation development. However, further validations of causality are still needed for many implicated genes. Genetic variants at identified loci also help predict individual atrial fibrillation risk and response to different therapies. SUMMARY: Continued advances in the field of genetics and molecular biology have led to significant insight into the genetic underpinnings of atrial fibrillation. Potential clinical applications of these studies include the identification of new therapeutic targets and development of genetic risk scores to optimize management of this common cardiac arrhythmia.
Authors: Jun Wang; Elzbieta Klysik; Subeena Sood; Randy L Johnson; Xander H T Wehrens; James F Martin Journal: Proc Natl Acad Sci U S A Date: 2010-05-10 Impact factor: 11.205
Authors: Mathilda T M Mommersteeg; Nigel A Brown; Owen W J Prall; Corrie de Gier-de Vries; Richard P Harvey; Antoon F M Moorman; Vincent M Christoffels Journal: Circ Res Date: 2007-09-06 Impact factor: 17.367
Authors: Daniel F Gudbjartsson; Hilma Holm; Patrick Sulem; Gisli Masson; Asmundur Oddsson; Olafur Th Magnusson; Jona Saemundsdottir; Hafdis Th Helgadottir; Hannes Helgason; Hrefna Johannsdottir; Solveig Gretarsdottir; Sigurjon A Gudjonsson; Inger Njølstad; Maja-Lisa Løchen; Larry Baum; Ronald C W Ma; Gunnlaugur Sigfusson; Augustine Kong; Guðmundur Thorgeirsson; Jon Th Sverrisson; Unnur Thorsteinsdottir; Kari Stefansson; David O Arnar Journal: Eur Heart J Date: 2016-10-14 Impact factor: 29.983
Authors: Jonathan P Piccini; William T Abraham; Christopher Dufton; Ian A Carroll; Jeff S Healey; Dirk J van Veldhuisen; William H Sauer; Inder S Anand; Michel White; Stephen B Wilton; Ryan Aleong; Michiel Rienstra; Steven K Krueger; Felix Ayala-Paredes; Yaariv Khaykin; Bela Merkely; Vladimir Miloradović; Jerzy K Wranicz; Leonard Ilkhanoff; Paul D Ziegler; Gordon Davis; Laura L Emery; Debra Marshall; David P Kao; Michael R Bristow; Stuart J Connolly Journal: JACC Heart Fail Date: 2019-04-29 Impact factor: 12.035
Authors: Biqi Wang; Kathryn L Lunetta; Josée Dupuis; Steven A Lubitz; Ludovic Trinquart; Lixia Yao; Patrick T Ellinor; Emelia J Benjamin; Honghuang Lin Journal: Circ Res Date: 2019-12-05 Impact factor: 17.367
Authors: R Brugada; T Tapscott; G Z Czernuszewicz; A J Marian; A Iglesias; L Mont; J Brugada; J Girona; A Domingo; L L Bachinski; R Roberts Journal: N Engl J Med Date: 1997-03-27 Impact factor: 91.245
Authors: Seung Hoan Choi; Lu-Chen Weng; Carolina Roselli; Honghuang Lin; Christopher M Haggerty; M Benjamin Shoemaker; John Barnard; Dan E Arking; Daniel I Chasman; Christine M Albert; Mark Chaffin; Nathan R Tucker; Jonathan D Smith; Namrata Gupta; Stacey Gabriel; Lauren Margolin; Marisa A Shea; Christian M Shaffer; Zachary T Yoneda; Eric Boerwinkle; Nicholas L Smith; Edwin K Silverman; Susan Redline; Ramachandran S Vasan; Esteban G Burchard; Stephanie M Gogarten; Cecelia Laurie; Thomas W Blackwell; Gonçalo Abecasis; David J Carey; Brandon K Fornwalt; Diane T Smelser; Aris Baras; Frederick E Dewey; Cashell E Jaquish; George J Papanicolaou; Nona Sotoodehnia; David R Van Wagoner; Bruce M Psaty; Sekar Kathiresan; Dawood Darbar; Alvaro Alonso; Susan R Heckbert; Mina K Chung; Dan M Roden; Emelia J Benjamin; Michael F Murray; Kathryn L Lunetta; Steven A Lubitz; Patrick T Ellinor Journal: JAMA Date: 2018-12-11 Impact factor: 56.272
Authors: Eue-Keun Choi; Jae Hyung Park; Ji-Young Lee; Chung Mo Nam; Min Ki Hwang; Jae-Sun Uhm; Boyoung Joung; Young-Guk Ko; Moon-Hyoung Lee; Steven A Lubitz; Patrick T Ellinor; Hui-Nam Pak Journal: J Am Heart Assoc Date: 2015-08-13 Impact factor: 5.501